"
ABSTRACT
The accumulation of somatic mitochondrial DNA
(mtDNA) mutations contributes to the pathogene-
sis of human disease. Currently, mitochondrial mu-
tations are largely considered results of inaccurate
processing of its heavily damaged genome. However,
mainly from a lack of methods to monitor mtDNA
mutations with sufficient sensitivity and accuracy,
a link between mtDNA damage and mutation has
not been established. To test the hypothesis that
mtDNA-damaging agents induce mtDNA mutations,
we exposed MutaTM Mouse mice to benzo[a]pyrene(B[a]P) or
N-ethyl-N-nitrosourea (ENU), daily for 28
consecutive days, and quantified mtDNA point and
deletion mutations in bone marrow and liver using
our newly developed Digital Random Mutation Cap-
ture (dRMC) and Digital Deletion Detection (3D) as-
says. Surprisingly, our results demonstrate muta-
gen treatment did not increase mitochondrial point
or deletion mutation frequencies, despite evidence
both compounds increase nuclear DNA mutations
and demonstrated B[a]P adduct formation in mtDNA.
These findings contradict models of mtDNA muta-
genesis that assert the elevated rate of mtDNA mu-
tation stems from damage sensitivity and abridged
repair capacity. Rather, our results demonstrate in-
duced mtDNA damage does not readily convert into
mutation. These findings suggest robust mitochon-
drial damage responses repress induced mutations
after mutagen exposure.
"
... it's time for "question of the month" ... lol
http://nar.oxfordjou...6.full.pdf html